178 related articles for article (PubMed ID: 22048815)
1. Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival.
Weigman VJ; Chao HH; Shabalin AA; He X; Parker JS; Nordgard SH; Grushko T; Huo D; Nwachukwu C; Nobel A; Kristensen VN; Børresen-Dale AL; Olopade OI; Perou CM
Breast Cancer Res Treat; 2012 Jun; 133(3):865-80. PubMed ID: 22048815
[TBL] [Abstract][Full Text] [Related]
2. Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics.
Jönsson G; Staaf J; Vallon-Christersson J; Ringnér M; Holm K; Hegardt C; Gunnarsson H; Fagerholm R; Strand C; Agnarsson BA; Kilpivaara O; Luts L; Heikkilä P; Aittomäki K; Blomqvist C; Loman N; Malmström P; Olsson H; Johannsson OT; Arason A; Nevanlinna H; Barkardottir RB; Borg A
Breast Cancer Res; 2010; 12(3):R42. PubMed ID: 20576095
[TBL] [Abstract][Full Text] [Related]
3. Proper genomic profiling of (BRCA1-mutated) basal-like breast carcinomas requires prior removal of tumor infiltrating lymphocytes.
Massink MP; Kooi IE; van Mil SE; Jordanova ES; Ameziane N; Dorsman JC; van Beek DM; van der Voorn JP; Sie D; Ylstra B; van Deurzen CH; Martens JW; Smid M; Sieuwerts AM; de Weerd V; Foekens JA; van den Ouweland AM; van Dyk E; Nederlof PM; Waisfisz Q; Meijers-Heijboer H
Mol Oncol; 2015 Apr; 9(4):877-88. PubMed ID: 25616998
[TBL] [Abstract][Full Text] [Related]
4. BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal-like breast cancers.
Tkocz D; Crawford NT; Buckley NE; Berry FB; Kennedy RD; Gorski JJ; Harkin DP; Mullan PB
Oncogene; 2012 Aug; 31(32):3667-78. PubMed ID: 22120723
[TBL] [Abstract][Full Text] [Related]
5. Basal-like breast cancer: molecular profiles, clinical features and survival outcomes.
Milioli HH; Tishchenko I; Riveros C; Berretta R; Moscato P
BMC Med Genomics; 2017 Mar; 10(1):19. PubMed ID: 28351365
[TBL] [Abstract][Full Text] [Related]
6. Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies.
Toft DJ; Cryns VL
Mol Endocrinol; 2011 Feb; 25(2):199-211. PubMed ID: 20861225
[TBL] [Abstract][Full Text] [Related]
7. Recurrent patterns of DNA copy number alterations in tumors reflect metabolic selection pressures.
Graham NA; Minasyan A; Lomova A; Cass A; Balanis NG; Friedman M; Chan S; Zhao S; Delgado A; Go J; Beck L; Hurtz C; Ng C; Qiao R; Ten Hoeve J; Palaskas N; Wu H; Müschen M; Multani AS; Port E; Larson SM; Schultz N; Braas D; Christofk HR; Mellinghoff IK; Graeber TG
Mol Syst Biol; 2017 Feb; 13(2):914. PubMed ID: 28202506
[TBL] [Abstract][Full Text] [Related]
8. Integrative genomic and transcriptomic analysis for pinpointing recurrent alterations of plant homeodomain genes and their clinical significance in breast cancer.
Yu H; Jiang Y; Liu L; Shan W; Chu X; Yang Z; Yang ZQ
Oncotarget; 2017 Feb; 8(8):13099-13115. PubMed ID: 28055972
[TBL] [Abstract][Full Text] [Related]
9. Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair.
Saal LH; Gruvberger-Saal SK; Persson C; Lövgren K; Jumppanen M; Staaf J; Jönsson G; Pires MM; Maurer M; Holm K; Koujak S; Subramaniyam S; Vallon-Christersson J; Olsson H; Su T; Memeo L; Ludwig T; Ethier SP; Krogh M; Szabolcs M; Murty VV; Isola J; Hibshoosh H; Parsons R; Borg A
Nat Genet; 2008 Jan; 40(1):102-7. PubMed ID: 18066063
[TBL] [Abstract][Full Text] [Related]
10. Molecular subtyping of breast cancer: opportunities for new therapeutic approaches.
Mullan PB; Millikan RC
Cell Mol Life Sci; 2007 Dec; 64(24):3219-32. PubMed ID: 17957336
[TBL] [Abstract][Full Text] [Related]
11. Replicative Instability Drives Cancer Progression.
Morris BB; Smith JP; Zhang Q; Jiang Z; Hampton OA; Churchman ML; Arnold SM; Owen DH; Gray JE; Dillon PM; Soliman HH; Stover DG; Colman H; Chakravarti A; Shain KH; Silva AS; Villano JL; Vogelbaum MA; Borges VF; Akerley WL; Gentzler RD; Hall RD; Matsen CB; Ulrich CM; Post AR; Nix DA; Singer EA; Larner JM; Stukenberg PT; Jones DR; Mayo MW
Biomolecules; 2022 Oct; 12(11):. PubMed ID: 36358918
[TBL] [Abstract][Full Text] [Related]
12. Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple Metastases.
Hoadley KA; Siegel MB; Kanchi KL; Miller CA; Ding L; Zhao W; He X; Parker JS; Wendl MC; Fulton RS; Demeter RT; Wilson RK; Carey LA; Perou CM; Mardis ER
PLoS Med; 2016 Dec; 13(12):e1002174. PubMed ID: 27923045
[TBL] [Abstract][Full Text] [Related]
13. DNA copy number motifs are strong and independent predictors of survival in breast cancer.
Pladsen AV; Nilsen G; Rueda OM; Aure MR; Borgan Ø; Liestøl K; Vitelli V; Frigessi A; Langerød A; Mathelier A; ; Engebråten O; Kristensen V; Wedge DC; Van Loo P; Caldas C; Børresen-Dale AL; Russnes HG; Lingjærde OC
Commun Biol; 2020 Apr; 3(1):153. PubMed ID: 32242091
[TBL] [Abstract][Full Text] [Related]
14. Statistical measures of transcriptional diversity capture genomic heterogeneity of cancer.
Jiang T; Shi W; Natowicz R; Ononye SN; Wali VB; Kluger Y; Pusztai L; Hatzis C
BMC Genomics; 2014 Oct; 15(1):876. PubMed ID: 25294321
[TBL] [Abstract][Full Text] [Related]
15. Identification of Copy Number Aberrations in Breast Cancer Subtypes Using Persistence Topology.
Arsuaga J; Borrman T; Cavalcante R; Gonzalez G; Park C
Microarrays (Basel); 2015 Aug; 4(3):339-69. PubMed ID: 27600228
[TBL] [Abstract][Full Text] [Related]
16. Classification of HER2-negative breast cancers by
Loh JW; Lim AH; Chan JY; Yap YS
Ther Adv Med Oncol; 2023; 15():17588359231206259. PubMed ID: 37920257
[TBL] [Abstract][Full Text] [Related]
17. Breast Cancer Molecular Stratification: From Intrinsic Subtypes to Integrative Clusters.
Russnes HG; Lingjærde OC; Børresen-Dale AL; Caldas C
Am J Pathol; 2017 Oct; 187(10):2152-2162. PubMed ID: 28733194
[TBL] [Abstract][Full Text] [Related]
18. Structural and genic characterization of stable genomic regions in breast cancer: relevance to chemotherapy.
Park NI; Rogan PK; Tarnowski HE; Knoll JH
Mol Oncol; 2012 Jun; 6(3):347-59. PubMed ID: 22342187
[TBL] [Abstract][Full Text] [Related]
19. Patterns of cell cycle checkpoint deregulation associated with intrinsic molecular subtypes of human breast cancer cells.
Bower JJ; Vance LD; Psioda M; Smith-Roe SL; Simpson DA; Ibrahim JG; Hoadley KA; Perou CM; Kaufmann WK
NPJ Breast Cancer; 2017; 3():9. PubMed ID: 28649649
[TBL] [Abstract][Full Text] [Related]
20. CVAM: CNA Profile Inference of the Spatial Transcriptome Based on the VGAE and HMM.
Ma J; Guo J; Fan Z; Zhao W; Zhou X
Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
